| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.90T | 1.88T | 1.89T | 1.68T | 1.43T | 1.25T |
| Gross Profit | 294.81B | 315.62B | 317.75B | 285.11B | 235.83B | 198.67B |
| EBITDA | 147.82B | 135.27B | 143.88B | 121.14B | 107.62B | 78.97B |
| Net Income | 25.11B | 13.71B | 40.26B | 34.28B | 20.68B | 800.00M |
Balance Sheet | ||||||
| Total Assets | 1.59T | 1.57T | 1.63T | 1.44T | 1.39T | 1.29T |
| Cash, Cash Equivalents and Short-Term Investments | 130.46B | 119.06B | 167.02B | 123.85B | 124.25B | 118.64B |
| Total Debt | 243.90B | 248.36B | 250.84B | 263.34B | 268.50B | 291.49B |
| Total Liabilities | 775.23B | 787.92B | 805.74B | 740.62B | 726.04B | 706.21B |
| Stockholders Equity | 777.45B | 745.04B | 788.98B | 667.23B | 624.01B | 550.91B |
Cash Flow | ||||||
| Free Cash Flow | 12.39B | -8.06B | 95.72B | 22.50B | 24.36B | 36.51B |
| Operating Cash Flow | 101.35B | 80.24B | 154.46B | 78.28B | 67.04B | 91.76B |
| Investing Cash Flow | -84.32B | -75.94B | -71.35B | -52.11B | -25.27B | -52.52B |
| Financing Cash Flow | -43.46B | -52.08B | -47.22B | -28.71B | -43.53B | -57.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥499.02B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥520.01B | 11.33 | ― | 2.60% | 1.06% | -5.99% | |
68 Neutral | ¥572.67B | 28.26 | ― | 3.52% | 1.43% | 83.34% | |
67 Neutral | ¥5.32T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
63 Neutral | ¥561.86B | 15.03 | 3.35% | 3.18% | 0.44% | -11.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥1.69T | 14.23 | 8.34% | 2.03% | 4.33% | 524.86% |